Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.4695
-0.0205 (-4.18%)
Mar 31, 2025, 9:30 AM EST - Market open
Lineage Cell Therapeutics Employees
As of December 31, 2024, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees increased by 2 or 2.67% compared to the previous year.
Employees
77
Change (1Y)
2
Growth (1Y)
2.67%
Revenue / Employee
$123,364
Profits / Employee
-$241,675
Market Cap
107.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LCTX News
- 20 days ago - Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 26 days ago - Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025 - Business Wire
- 6 weeks ago - Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury - Business Wire
- 7 weeks ago - Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference - Business Wire
- 2 months ago - Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering - Business Wire
- 3 months ago - Lineage Cell Therapeutics Issues Letter to Stockholders - Business Wire
- 4 months ago - Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering - Business Wire